Table 2: Zinc concentrations in serum (µg/100 ml) and tissues (µg/g dry weight) of control and experimental animals.
Parameters | Control (n = 10) | Non-diabetic+Ca (n = 10) | Non-diabetic+Ca+Zn (n = 10) | Diabetic (n = 10) | Diabetic+Ca (n = 10) | Diabetic+Ca+Zn (n = 10) |
Serum | 153.80 ± 3.10 | 137.50 ± 1.61* | 161.80 ± 3.02*a2 | 90.30 ± 1.43*** | 81.1 ± 1.22***b1 | 102.31 ± 2.54***c2 |
Liver | 35.19 ± 1.75 | 31.83 ± 1.74* | 40.51 ± 1.35*a1 | 28.59 ± 1.18** | 24.54 ± 0.91***b | 30.86 ± 0.70*c1 |
Kidney | 39.70 ± 1.31 | 34.35 ± 1.68* | 46.20 ± 1.91*a2 | 35.19 ± 0.82 | 32.0 ± 0.78***b | 42.00 ± 1.26*c2 |
Pancreas | 61.06 ± 1.55 | 56.41 ± 2.03* | 64.53 ± 2.68a1 | 59.82 ± 1.39 | 55.01 ± 5.03**b1 | 63.41 ± 2.01c1 |
Values are mean ± SEM, n = number of samples.
*p < 0.05; **p < 0.01; ***p < 0.001: all groups versus control group; a1p < 0.01; a2p < 0.001: non-diabetic+Ca+Zn versus non-diabetic calcium group; bp < 0.05; b1p < 0.01: diabetic+Ca versus diabetic group; c1p < 0.01; c2p < 0.001: diabetic+Ca+Zn versus diabetic calcium group.